20180326: ICC ANO2 IgG in Multiple Sclerosis patients (168 – 211, 153)

Objectives: To test Multiple Sclerosis patients for IgG positivity towards ANO2

Patients:  168 to 211 (from the Multiple Sclerosis sera collection) + 153 (without commercial antibody) + negative control

ANO2 ICC:

  • HEKs 293 Cells Transfection: 12.03.2018
  • Blocking solution: Goat Serum diluted 5% in PBS.
  • Patient’s sera diluted 1/100 with 5 % Goat Serum
  • Primary antibody: ANO2 (TA316534 OriGene) diluted 1/500.
  • Secondary antibodies: GAR 488 + GAH 594 IgG (1/1000)
  • Vectashield mounting medium.

Result: all samples (168-211) were negative. 153 positive

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.